AG0035C3

57149-07-2 | 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol

AG0035C3

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	57149-07-2
Catalog Number	AG0035C3(AGN-PC-009E5B)
Chemical Name	1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol
IUPAC Name	1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol
InChI	InChI=1S/C24H28N2O3/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23/h2-12,20,27H,13-18H2,1H3
InChI Key	HRRBJVNMSRJFHQ-UHFFFAOYSA-N
MDL Number	MFCD00242741
Molecular Formula	C24H28N2O3
Molecular Weight	392.4907
NSC Number	759293
SMILES	OC(COc1cccc2ccccc12)CN4CCN(c3ccccc3(OC))CC4
Synonyms	1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol, naftopidil, naftopidil, 57149-07-2, Flivas, KT-611, Naftopidil [INN], Avishot, Naftopidilum [Latin], Naftopidil (Flivas), BM-15275, Naftopidil (unspecified), BRN 0629965, CHEMBL142635, C24H28N2O3, 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol, NCGC00015718-06, (+-)-1-(4-(2-Methoxyphenyl)piperazinyl)-3-(1-naphthyloxy)propan-2-ol, (RS)-1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol, 1-Pioerazineethanol, 4-(2-methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-, 4-(2-Methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-1-pioerazineethanol, DSSTox_CID_25176, DSSTox_RID_80725, DSSTox_GSID_45176, Naftopidilum, (+-)-4-(o-Methoxyphenyl)-alpha-((1-naphthyloxy)methyl)-1-piperazineethanol, 4-(2-methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol, SMR000466346, CAS-57149-07-2, 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol, Naftopidil,(S), Naftopidil(Flivas), Flivas (TN), Prestwick0_000975, Prestwick1_000975, Prestwick2_000975, Prestwick3_000975, Naftopidil (JP17/INN), AC1L1I4G, AC1Q77IN, cid_4418, Naftopidil tablets (JP17), Lopac0_000941, REGID_for_CID_4418, BSPBio_001009, MLS000759459, MLS001424117, SCHEMBL113215, SPBio_002920, BPBio1_001111, DTXSID5045176, BDBM50773, CHEBI:31891, cid_6603044, KS-00000XJU, HMS2051B09, HMS2089G07, HMS3393B09, HMS3655H21, Pharmakon1600-01506024, BCP21786, HY-B0391, 3-(naphthalen-1-yloxy)propan-2-ol, Tox21_110205, 1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol, BBL028454, MFCD00242741, MFCD11046013, NSC759293, s2126, STL372645, AKOS002279617, AKOS016328058, Tox21_110205_1, BCP9000976, CCG-100935, CCG-205022, CS-2477, DB12092, FE-0209, KT-611;BM-15275;Avishot;Flivas, MCULE-8827578135, NC00185, NSC-759293, SB19321, NCGC00015718-04, NCGC00015718-05, NCGC00015718-08, NCGC00015718-09, NCGC00015718-10, NCGC00015718-12, NCGC00024672-03, NCGC00024672-04, AN-40014, BC205447, CPD000466346, O220, SAM001246658, SC-25905, 1-(4-(2-methoxyphenyl)piperazin-1-yl)-, SBI-0050915.P002, AB0016337, AB2000527, LS-112431, AB00514643, FT-0630696, N0832, ST24048774, ST50794017, SW196570-4, 49N072, D01674, 27822-EP2270011A1, 27822-EP2298767A1, 27822-EP2314587A1, AB00489961-18, AB00489961-19, AB00489961_20, AB00489961_21, Naftopidil orally disintegrating tablets (JP17), BRD-A01787639-300-03-7, BRD-A01787639-300-04-5, 1-[4-(2-methoxyphenyl)piperazinyl]-3-naphthyloxypropan-2-ol, 1-[4-(2-Methoxyphenyl)piperazinyl]-3-(1-naphthyloxy)propan-2-ol, 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(1-naphthyloxy)propan-2-ol, 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol, 1-[4-(2-methoxyphenyl)piperazino]-3-(1-naphthoxy)propan-2-ol;hydrochloride, 4-(2-methoxyphenyl)-|A-((1-naphthalenyloxy)methyl)-1-piperazineethanol, 1-[4-(2-methoxyphenyl)-1-piperazinyl]-3-(1-naphthalenyloxy)-2-propanol;hydrochloride, 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxy-propan-2-ol;hydrochloride, 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol;hydrochloride, 4-(2-Methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol hydrochloride hydrate, naftopil, naftopidil HCl, Naftopidil?, NAFTOPIDIL DIHYDROCHLORIDE, UNII-R9PHW59SFN, Naftopidildihydrochloride, Naftopidil, 98% 5g, R9PHW59SFN, D04DKH, MLS000069363, NAFTOPIDIL HYDROCHLORIDE, CID4418, AC-144, AR-1J0786, C24-H28-N2-O3, CS-O-30675, SMR000058489, 5-23-02-00135 (Beilstein Handbook Reference), C064357, 4-(2-Methoxyphenyl)alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol, RS-1-[4-(2-methoxyphenyl)-1-piperazinyl]-3-(1-naphthoxy)-2-propanol, Naftopidil, 98%, a selective alpha1-adrenergic receptor antagonist - 25G 25g, 57149-08-3, 59149-19-8,

Complexity	483
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	392.21g/mol
Formal Charge	0
Heavy Atom Count	29
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	392.499g/mol
Monoisotopic Mass	392.21g/mol
Rotatable Bond Count	7
Topological Polar Surface Area	45.2A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	4.1

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number